Orphan Drugs & Rare Diseases — SMi's 9th Annual Orphan Drugs & Rare Diseases

SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference, taking place on the 15th and 16th October 2019 in London, UK. The orphan drug market is continuously growing and is expected to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020, orphan drugs are set to account for 19% of global prescription sales.

Topics: Patient recruitment, Reimbursement, Patient Groups, Orphan Drugs, Gene therapy, Orphan Drugs, Rare Diseases, Gene Therapy, Clinical Trials